70% of Listed Meds Likely to Face Off-Year Re-Pricing If Prior Threshold Applied: MHLW

Nearly 70% of all listed medicines will be caught by cuts in the drug price revision next April if the product coverage threshold used in the previous FY2021 “off-year” re-pricing is adopted this time, leading to a reduction of 490...read more